Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma

Magnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, Susanne Berglund, Antonio Piras, Parmis Blomgran, Anders Cavallin, Mia Collins, Göran Dahl, Bilel Dekkak, Therese Ericsson, Niklas Hagberg, Ann Aurell Holmberg, Agnes Leffler, Anders J Lundqvist, Thomais Markou, James Pinkerton, Lars Rönnblom, Stacey Siu, Vanessa Taylor, Tiiu Wennberg, Dimitrios Zervas, Arian D J Laurence, Suman Mitra, Maria G Belvisi, Mark Birrell, Annika Borde

Open source

DOI: 10.2147/dddt.s354291
Published: 2022-08
Container: Drug Design, Development and Therapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s354291,
  title = {Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma},
  author = {Magnus Nilsson and Magdalena Rhedin and Ramon Hendrickx and Susanne Berglund and Antonio Piras and Parmis Blomgran and Anders Cavallin and Mia Collins and Göran Dahl and Bilel Dekkak and Therese Ericsson and Niklas Hagberg and Ann Aurell Holmberg and Agnes Leffler and Anders J Lundqvist and Thomais Markou and James Pinkerton and Lars Rönnblom and Stacey Siu and Vanessa Taylor and Tiiu Wennberg and Dimitrios Zervas and Arian D J Laurence and Suman Mitra and Maria G Belvisi and Mark Birrell and Annika Borde},
  year = {2022},
  journal = {Drug Design, Development and Therapy},
  doi = {10.2147/dddt.s354291},
  url = {https://doi.org/10.2147/dddt.s354291}
}

RIS

TY  - JOUR
TI  - Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma
AU  - Magnus Nilsson
AU  - Magdalena Rhedin
AU  - Ramon Hendrickx
AU  - Susanne Berglund
AU  - Antonio Piras
AU  - Parmis Blomgran
AU  - Anders Cavallin
AU  - Mia Collins
AU  - Göran Dahl
AU  - Bilel Dekkak
AU  - Therese Ericsson
AU  - Niklas Hagberg
AU  - Ann Aurell Holmberg
AU  - Agnes Leffler
AU  - Anders J Lundqvist
AU  - Thomais Markou
AU  - James Pinkerton
AU  - Lars Rönnblom
AU  - Stacey Siu
AU  - Vanessa Taylor
AU  - Tiiu Wennberg
AU  - Dimitrios Zervas
AU  - Arian D J Laurence
AU  - Suman Mitra
AU  - Maria G Belvisi
AU  - Mark Birrell
AU  - Annika Borde
PY  - 2022
JO  - Drug Design, Development and Therapy
DO  - 10.2147/dddt.s354291
UR  - https://doi.org/10.2147/dddt.s354291
ER  -

APA

Nilsson, M., Rhedin, M., Hendrickx, R., Berglund, S., Piras, A., Blomgran, P., Cavallin, A., Collins, M., Dahl, G., Dekkak, B., Ericsson, T., Hagberg, N., Holmberg, A. A., Leffler, A., Lundqvist, A. J., Markou, T., Pinkerton, J., Rönnblom, L., Siu, S., Taylor, V., Wennberg, T., Zervas, D., Laurence, A. D. J., Mitra, S., Belvisi, M. G., Birrell, M., & Borde, A. (2022). Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s354291

Source records

crossref · retrieved 2026-09-25T18:51:19.170Z